Anti-tumor necrosis alpha therapy in the management of refractory pediatric Behcets uveitis

Basit Öğe Kaydı
dc.contributor.authorEsen, F.
dc.contributor.authorTurkyilmaz, O.
dc.date.accessioned2025-05-10T19:27:52Z
dc.date.issued2018
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpageS176
dc.identifier.issn0392-856X
dc.identifier.issn1593-098X
dc.identifier.issue6
dc.identifier.scopusqualityQ2
dc.identifier.startpageS176
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7100
dc.identifier.volume36
dc.identifier.wosWOS:000473246600085
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherClinical & Exper Rheumatology
dc.relation.ispartofClinical and Experimental Rheumatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleAnti-tumor necrosis alpha therapy in the management of refractory pediatric Behcets uveitis
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu